Compare stocks

OSE Immunotherapeutics SA is a biotechnology company focused on the research and development of immunotherapies in the fields of immune-oncology, autoimmune diseases, and transplantation. The company aims to innovate through its pipeline, which includes products such as Tedopi, a therapeutic vaccine for non-small cell lung cancer, and CoVepiT, a COVID-19 vaccine. Founded in 2012 and headquartered in Nantes, France, OSE Immunotherapeutics combines strong scientific expertise with a strategic emphasis on building a diversified portfolio of advanced clinical trials. The company's competitive strength lies in its proprietary technologies and strategic partnerships, enhancing its capabilities to address significant unmet medical needs globally.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.